How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
- 1 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 66 (4), 1297-1305
- https://doi.org/10.1007/s10620-020-06269-4
Abstract
Background and Aims The objective of our study was to determine the concordance rates of steatosis staging by controlled attenuation parameter (CAP) scores from transient elastography (TE) in comparison with liver histology in patients with chronic liver disease and to determine the optimal CAP cutoffs to predict the severity of steatosis and identify those with nonalcoholic steatohepatitis (NASH). Methods Patients (n = 217) who had both CAP scores and liver biopsy within a period of 90 days were retrospectively studied. Histology was graded in a blinded fashion by a single pathologist; steatosis was graded on a scale from 0 to 3. Nonalcoholic fatty liver disease activity scores (NAS) scores were calculated for all patients. Optimal CAP cut-points were selected by maximum Youden's index. Results Area under receiver operating characteristic curve (AUROC) for CAP (using cutoff value >= 278 dB/m) in differentiating steatosis 1-3 from 0 was 0.82 (95% CI 0.75-0.89), and 0.79 (95% CI 0.70-0.88) in differentiating steatosis 0-1 from 2 to 3 using CAP cutoff value >= 301 dB/m. With CAP cutoff value >= 301 dB/m, CAP identified NAS 3 or above with AUROC of 0.82 (95% CI 0.74-0.89). The AUROC for TE in differentiating fibrosis (cutoff 11.9 kPa) 3-4 from 0 to 2 was 0.85 (95% CI 0.77-0.92), and 0.84 (95% CI 0.74-0.93) in differentiating (cutoff 14.4 kPa) 4 from 0 to 3. Conclusions Transient elastography is a good modality to accurately diagnose steatosis and NASH and can also differentiate advanced liver fibrosis from early stages.Keywords
This publication has 18 references indexed in Scilit:
- Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver DiseaseGastroenterology, 2017
- The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver DiseaseAmerican Journal Of Gastroenterology, 2016
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient ElastographyGastroenterology, 2016
- Nonalcoholic Fatty Liver DiseaseJAMA, 2015
- FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States PracticeClinical Gastroenterology and Hepatology, 2015
- Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragmentsAlimentary Pharmacology & Therapeutics, 2013
- The global NAFLD epidemicNature Reviews Gastroenterology & Hepatology, 2013
- Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosisHepatology, 2008
- Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damageHepatology, 2007
- Acute viral hepatitis increases liver stiffness values measured by transient elastographyHepatology, 2007